# OnCo record cancer-treatment-bone-loss (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/cancer-treatment-bone-loss/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "cancer-treatment-bone-loss" ;
  schema:name "Bone loss caused by cancer treatment, and what rebuilds it"@en ;
  schema:description "Hormone treatments, chemotherapy that stops the ovaries and long courses of steroids all thin the bones, fast enough to measure within a year. Some of it comes back when the treatment stops, and the drugs that prevent fracture while it is going on are well proven."@en ;
  schema:url <https://onco.cc/technologies/cancer-treatment-bone-loss/> ;
  schema:dateModified "2026-10-02"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Osteoporosis> ;
  schema:citation <https://doi.org/10.1200/JCO.19.01696>, <https://doi.org/10.1056/NEJMoa010845>, <https://doi.org/10.1200/JCO.2007.11.0726>, <https://doi.org/10.1093/annonc/mdq541>, <https://doi.org/10.1200/JCO.2001.19.14.3306>, <https://doi.org/10.1016/S0140-6736(15)60995-3>, <https://doi.org/10.1056/NEJMoa0809003>, <https://doi.org/10.1056/NEJMoa2202106> ;
  onco:status "standard-of-care" ;
  onco:tag "rejuvenation", "survivorship", "evidence:strong" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/multiple-myeloma/>, <https://onco.cc/cancers/dlbcl/> ;
  onco:sections <https://onco.cc/fronts/rejuvenation/>, <https://onco.cc/fronts/supportive-care/>, <https://onco.cc/fronts/hormonal/> ;
  onco:technologies <https://onco.cc/technologies/bone-modifying-agents/>, <https://onco.cc/technologies/survivorship-care-plan/>, <https://onco.cc/technologies/exercise-prescription-after-cancer/>, <https://onco.cc/technologies/vitamin-d-omega3-supplementation/>, <https://onco.cc/technologies/androgen-deprivation/>, <https://onco.cc/technologies/endocrine-therapy/> ;
  onco:drugs <https://onco.cc/drugs/denosumab/>, <https://onco.cc/drugs/zoledronic-acid/>, <https://onco.cc/drugs/letrozole/>, <https://onco.cc/drugs/anastrozole/>, <https://onco.cc/drugs/exemestane/>, <https://onco.cc/drugs/leuprolide/>, <https://onco.cc/drugs/goserelin/>, <https://onco.cc/drugs/tamoxifen/> ;
  onco:terms <https://onco.cc/terms/treatment-induced-bone-loss/>, <https://onco.cc/terms/late-effects/>, <https://onco.cc/terms/aromatase-inhibitor/>, <https://onco.cc/terms/ovarian-function-suppression/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-survivorship/> .